Passage BIO (PASG) Cash & Equivalents (2019 - 2026)
Passage BIO's Cash & Equivalents was $24.2 million in Q2 2026, down 58.0% from $57.63 million a year earlier and down 27.4% from the prior quarter.
Powered by 
Analysis
Passage BIO (PASG) Cash & Equivalents (2019 - 2026) Analysis & Trends
At the end of FY2025, Cash & Equivalents at Passage BIO came in at $46.3 million, up 23.2% from FY2024.
- Cash & Equivalents shows a five-year compound annual growth rate of -19.3% (FY2020 to FY2025).
- In earlier years, Cash & Equivalents was $37.57 million in FY2024 (+73.1%), $21.71 million in FY2023 (-37.3%), $34.6 million in FY2022 (-73.2%) and $128.97 million in FY2021 (-4.5%).
- The Q2 2026 figure marks the lowest quarterly Cash & Equivalents since Q4 2023.
- Compared with a year earlier, Cash & Equivalents was higher in five of the last eight quarters, with growth averaging 31.9%.
- The best year-over-year quarter for Cash & Equivalents over five years was Q2 2025 (growth of 132.6%); the worst was Q4 2022 (a decline of 73.2%).
- Per Business Quant data, PASG's Cash & Equivalents in the three quarters before Q2 2026 was $33.34 million (Q1 2026), $46.3 million (Q4 2025) and $52.77 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | 20.42 Bn |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | 4.89 Bn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | 976.00 Mn |
| 10 | Passage BIO | 13.90 Mn | 13.90 Mn | - | 24.20 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 24.20 Mn |
| Mar 31, 2026 | 33.34 Mn |
| Dec 31, 2025 | 46.30 Mn |
| Sep 30, 2025 | 52.77 Mn |
| Jun 30, 2025 | 57.63 Mn |
| Mar 31, 2025 | 63.36 Mn |
| Dec 31, 2024 | 37.57 Mn |
| Sep 30, 2024 | 32.29 Mn |
| Jun 30, 2024 | 24.77 Mn |
| Mar 31, 2024 | 36.77 Mn |
| Dec 31, 2023 | 21.71 Mn |
| Sep 30, 2023 | 33.58 Mn |
| Jun 30, 2023 | 30.29 Mn |
| Mar 31, 2023 | 33.37 Mn |
| Dec 31, 2022 | 34.60 Mn |
| Sep 30, 2022 | 62.57 Mn |
| Jun 30, 2022 | 91.13 Mn |
| Mar 31, 2022 | 101.61 Mn |
| Dec 31, 2021 | 128.97 Mn |
| Sep 30, 2021 | 162.89 Mn |
API Access
Passage BIO Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=PASG&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "PASG", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=PASG&period=max&api_key=YOUR_API_KEY");
const data = await res.json();